Par Health USA
United States Updated 9 July 2026
Par Health USA is a finished-dose manufacturer based in United States. It appears in 62 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its most recent recorded inspection, by US FDA, closed on 20 October 2025 as OAI.
1
registered plants
1 with an FDA FEI number
62
filings
across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 20 October 2025 OAI US FDA
- 14 April 2023 VAI US FDA
- 22 October 2021 VAI US FDA
- 15 April 2019 VAI US FDA
- 9 August 2018 VAI US FDA
- 13 March 2017 VAI US FDA
- 28 September 2015 NAI US FDA
- 10 September 2015 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Rochester, United States | 1818977 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | 62 | None |
Comparing suppliers?
Choose your molecules and target markets. Par Health USA comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was OAI, on 20 October 2025.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability